Fitt Insider: Arora Health Launches Women's Health Study
Fitt Insider published Arora Health & Aesthetics' announcement of a new physician-led observational study focused on perimenopause, menopause, and advancing real-world clinical research in women's health.
Despite the growing demand for personalized hormone care and longevity medicine, significant gaps remain in the clinical evidence available to guide treatment during perimenopause. In the announcement, "Arora Health Launches Physician-Led Perimenopause Study to Expand Real-World Women's Health Clinical Research," Arora Health outlines its research initiative, developed in partnership with clinical research organization Veristat, to better understand women's health outcomes through real-world patient data.
Article highlights
The Fitt Insider announcement covers several key developments, including:
- Advancing clinical research in women's health. The observational study focuses on perimenopause, an often-understudied stage of women's health, with the goal of generating meaningful evidence to inform future treatment decisions and personalized care.
- Examining real-world patient experiences. The study will analyze de-identified clinical data from women receiving hormone replacement therapy and peptide therapy through Arora Health's telehealth platform, providing insights into routine care over time.
- Maintaining physician-led research oversight. Principal Investigator Nicolai Wohns, MD, leads the study with clinical oversight from Sean Arora, MD, CEO and Co-Founder, and Shannon Arora, MD, Chief Medical Officer.
- Partnering with Veristat to support research quality. The collaboration brings additional clinical research expertise, study design support, and regulatory guidance to help ensure scientific rigor and appropriate research standards.
- Prioritizing patient safety and continuity of care. As an observational study, the research does not introduce experimental treatments or require additional testing or procedures. Participants continue receiving their routine clinical care.
- Establishing a foundation for future evidence-based care. With Institutional Review Board (IRB) approval secured, the study aims to contribute valuable clinical insights that may help inform approaches to perimenopause, menopause, and women's hormone health.
Expanding the evidence behind women's health
The study reflects a growing need for more comprehensive research into how women experience hormonal changes and respond to personalized care during perimenopause and menopause.
As Principal Investigator Dr. Nicolai Wohns explains: “Women’s health, particularly perimenopause and menopause within longevity medicine, remains one of the most understudied areas in healthcare.”
Through this initiative, Arora Health aims to strengthen the connection between everyday clinical practice and evidence-based medicine. By examining de-identified patient information collected during routine care, the research team hopes to identify meaningful patterns that can contribute to a better understanding of women's health needs.
The study also reflects Arora's broader commitment to physician-led innovation, clinical accountability, and expanding access to personalized care. As research progresses, findings may help inform future treatment approaches and support more individualized care for women navigating hormonal changes.
Build what's next on a stronger clinical foundation.
Whether you're launching a new clinical program, expanding a clinic, entering new markets, or scaling a digital health platform, Arora helps you build the physician-led clinical and compliance infrastructure to do it responsibly.